SS Innovations International, Inc. SSII
Medical/Dental Instruments · data as of November 13, 2026
SS Innovations International, Inc. (SSII) is a healthcare company listed in the US with a market value of about $333M. In the twelve months to June 30, 2026 it had revenue of $52M and net income of -$12M, a net margin of -23.7%.
Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).
Key numbers: a 5-year average ROIC of -50%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 90% below the current price.
About SS Innovations International
SS Innovations International is listed in the US and classified in medical/dental instruments. Revenue went from $1M in 2022 to $42M in 2025, growth of about 209.3% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 55% over three years (dilution for shareholders). It spends 9% of revenue on research and development.
Score: 1.2 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $52M | $42M | $21M | $6M | $1M | — | — | — | — | — | — |
| Net income | -$12M | -$12M | -$19M | -$21M | -$3M | -$1M | -$1M | -$3M | -$960322 | -$1M | -$484982 |
| Free cash flow | -$18M | -$22M | -$10M | -$16M | -$6M | — | — | -$424227 | — | — | — |
| EPS (diluted) | $-0.06 | $-0.06 | $-0.11 | $-0.14 | $-0.03 | $-0.05 | $-0.05 | $-0.16 | $-0.05 | $-0.05 | $-0.03 |
| Net margin | -23.7% | -28.5% | -92.7% | -355.4% | -223.8% | — | — | — | — | — | — |
| ROIC | — | -15.7% | -63.3% | -69.7% | — | — | — | — | — | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 1 analysts is $7.00, 322% above the current price; targets range from $7.00 to $7.00; the consensus rating is “none”; expected EPS is $-0.06 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is SS Innovations International stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 90% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does SS Innovations International pay a dividend?
Not currently.
Is SS Innovations International a good stock to buy?
We do not give buy or sell advice. SS Innovations International scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.